Sight is developing a variety of diagnostic tools, including a rapid complete blood count (CBC) finger-prick test that’s launching in Europe this week and is in clinical trials in the U.S.
Read more on Forbes here.
Sight is developing a variety of diagnostic tools, including a rapid complete blood count (CBC) finger-prick test that’s launching in Europe this week and is in clinical trials in the U.S.
Read more on Forbes here.
![[DouxMatok in Business Wire] DouxMatok Appoints a U.S. Based Executive Team to Accelerate Introduction of Incredo® Sugar, a Sugar Reduction Solution Based on Real Cane Sugar, in North America](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
